Abeona Therapeutics Inc vs iShares MSCI United Kingdom (FTSE) — how do they compare? Abeona Therapeutics Inc trades at $7.49 (market cap $421.19M), while iShares MSCI United Kingdom (FTSE) trades at $48.37. Which is the better fit depends on your goals.
| ABEO | EWU | |
|---|---|---|
Market Cap | $421.19M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $7.45 | $48.68 |
52-Week Low | $4.17 | $40.90 |
Enterprise Value | $276.10M | — |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →EWU is a country-specific ETF that tracks the performance of the United Kingdom equity market. It provides exposure to large and mid-sized UK companies, with significant weightings in financials, energy, and healthcare, including Shell, AstraZeneca, and HSBC.
Read more on EWU →